I. Introduction
Acetone, a volatile organic compound (VOC), has found extensive use as a solvent and raw material in the production of paints, cosmetics, plastics, rubber, and chemical intermediates [1], [2], [3]. However, it readily vaporizes and can easily be inhaled, leading to negative impacts on human health. Acetone concentrations exceeding 173 ppm can inflict severe damage to the central nervous system, culminating in symptoms such as headaches, coma, and vomiting [4], [5]. Furthermore, prolonged exposure to acetone has been linked to adverse effects on the eyes, throat, liver, and kidneys [6], [7]. Acetone is also highly flammable and explosive, with explosion limits ranging from 2.6% to 12%, thereby posing significant risks to human safety [8]. Notably, acetone serves as a crucial biomarker for diabetes. Clinical studies have demonstrated that diabetic patients exhibit a concentration of 1.8 ppm of acetone in their breath, compared to only 0.3–0.9 ppm in healthy individuals [9]. As such, monitoring exhaled acetone levels represents a noninvasive and effective method for detecting early-stage diabetes. To summarize, there exists a pressing requirement for a cost effective, fast response sensor capable of accurately measuring acetone concentrations with a low detection limit. Such sensors are essential for preserving human health and ensuring production and life safety.